Sundara Research
A cardiovascular-focused clinical research site delivering high-quality trials, compassionate patient care, and meaningful community engagement in Central Florida.
Quality & Compliance
Sundara maintains a rigorous quality management framework designed to meet the highest standards of GCP compliance, regulatory readiness, and data integrity — providing sponsors and CROs with confidence in the reliability of every study we conduct.
Comprehensive & SOP Program
Site-specific standard operating procedures governing all aspects of trial conduct, from screening through closeout, reviewed and updated regularly to align with current regulatory guidance.
GCP Compliance
All investigators and research staff are trained to current ICH E6(R2) Good Clinical Practice standards, with refresher training conducted annually.
Audit Readiness
Ongoing internal quality reviews and mock audit processes ensure the site is prepared for sponsor audits, CRO oversight visits, and FDA inspections at all times.
CAPA Process
Formal corrective and preventive action processes are in place to identify, document, resolve, and prevent recurrence of protocol deviations and quality findings.
Ongoing Training Program
Structured training curriculum for all staff covering GCP, protocol-specific requirements, therapeutic area knowledge, and emerging regulatory updates.
Sundara is actively seeking new partnerships in the following high-priority therapeutic areas — spanning core cardiovascular programs, advanced imaging, and next-generation precision medicine initiatives. Our patient population, investigator expertise, and onsite infrastructure are well-suited to support studies across each of these domains.
Cardiometabolic Disease
Integrated cardiovascular and metabolic programs including ASCVD, insulin resistance, and metabolic syndrome
CNS
Central nervous system programs with crossover cardiometabolic and neurological comorbidity populations.
Rare Disease
Orphan and rare cardiovascular conditions where our diverse, well-characterized patient registry supports enrollment.
Current Research Interests
Obesity
GLP-1, anti-obesity therapies, and weight management studies leveraging our large cardiometabolic population.
Cardiac Amyloidosis
ATTR and AL amyloidosis programs supported by dedicated onsite PET imaging, nuclear cardiology, and specialized diagnostic protocols.
Molecular Imaging
Biomarker-driven and molecularly targeted imaging trials leveraging our onsite PET and nuclear medicine infrastructure.
Nuclear Medicine
Diagnostic and therapeutic radiopharmaceutical studies across cardiovascular and oncology-adjacent indications.
Theranostics
Next-generation theranostic programs integrating diagnostic imaging with targeted therapeutic delivery — an emerging growth priority for Sundara.
Heart Failure
HFrEF, HFmrEF, and HFpEF programs with onsite echocardiography and experienced heart failure investigators.
Precision Medicine Programs
Genomics, biomarker-stratified, and personalized medicine trials aligned with Sundara's expanding molecular and imaging capabilities.
Cardiometabolic
Comprehensive cardiometabolic programs spanning ASCVD, insulin resistance, dyslipidemia, and metabolic syndrome with integrated cardiovascular and metabolic expertise.